A Randomized Cluster Trial to Evaluate a Mobile Mammography Unit in Breast Cancer Screening in France (Mammobile)
Mammobile
Evaluation of a Mobile Mammography Unit. A Randomized Cluster Trial Protocol of a Population Health Intervention Research to Reduce Breast Cancer Screening Disparities in Normandy, France (Mammobile)
1 other identifier
interventional
91,982
1 country
1
Brief Summary
Organized breast cancer screening (OBCS) has been implemented nationwide since 2004 inFrance, but the participation rate remains low (51%) and inequities in participation were reported. Strategies as mobile mammography units could be effective to increase participation in OBCS and reduce inequities, especially in underserved areas in regard to this screening. Our main objective is to evaluate this device and to identify how to incorporate a mobile unit in the OBCS with a view to tackle territorial inequities in OBCS participation. The project will be conducted as a randomized controlled cluster trial in 2022-2024, in remote areas of 4 French departments. The main intervention is to propose an appointment at the mobile unit in complement to the current OBCS in these remote areas. In addition, few weeks before this intervention, local actors will carry out actions to promote OBCS with mobile unit specific information tools. This randomized controlled trial will provide a high level of evidence in assessing the mobile unit effects on participation and inequities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2021
CompletedFirst Posted
Study publicly available on registry
December 21, 2021
CompletedStudy Start
First participant enrolled
February 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedDecember 21, 2021
November 1, 2021
2 years
December 3, 2021
December 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Aggregated breast cancer screening participation rate 3 months after the last invitation
Participation rate will be measure at area level and compare between intervention and control arm.
3 months after the last invitation at the end of the two years of the intervention
Individual breast cancer screening participation rate 3 months after the last invitation
It will also be assessed at indivdual level with multilevel logistic regression
3 months after the last invitation at the end of the two years of the intervention
Impact of the mobile unit on social inequalities in screening participation
Impact of the mobile mammography unit on social inequalities will be assessed by comparing intervention and control arm. Social statut is measure with an ecological deprivation index
3 months after the last invitation at the end of the two years of the intervention
Impact of the mobile unit on territorial inequalities in screening participation
impact of the mobile mammography unit territorial inequalities will be assessed by comparing intervention and control arm. The distance to the radiologiste center will be used as territorial mesure
3 months after the last invitation at the end of the two years of the intervention
Secondary Outcomes (5)
Informed choice to breast cancer screening for participating women
through study completion, an average of 3 month
Informed choice to breast cancer screening for non-participating women
Women will be considered as "non participating" 18 month after the invitation
Satisfaction to mammography
through study completion, an average of 3 month
Com-B Model Evaluation for participating women
through study completion, an average of 3 month
Com-B Model Evaluation for non-participating women
Women will be considered as "non participating" 18 month after the invitation
Study Arms (2)
Intervention
EXPERIMENTALWomen will receive a proposition for an appointment at the MMU in complement to the current screening invitation, keeping the choice of their place of screening. Women will also receive the timetable of prevention actions with the invitation to participate in screening.
Control
NO INTERVENTIONNo change from the usual breast cancer screening organization
Interventions
The main intervention will be a proposition for an appointment at the MMU in complement to the current OBCS
Eligibility Criteria
You may qualify if:
- women eligible to breast cancer screening campaign : aged 50 to 74 years, and with the only risk of breast cancer being age. The previous screening mammography dating from 22 months
You may not qualify if:
- outside the ages
- with specific risk of breast cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Université de Caen Normandielead
- National Cancer Institute, Francecollaborator
- Regional health agency, Normandy Francecollaborator
- Pink ribbon (Ruban Rose, France)collaborator
- Normandy regional cancer screening coordination centercollaborator
- Departmental councilscollaborator
Study Sites (1)
Normandy
Caen, Normandy, 14000, France
Related Publications (1)
Guillaume E, Rollet Q, Launay L, Beuriot S, Dejardin O, Notari A, Crevel E, Benhammouda A, Verzaux L, Quertier MC, Launoy G. Evaluation of a mobile mammography unit: concepts and randomized cluster trial protocol of a population health intervention research to reduce breast cancer screening inequalities. Trials. 2022 Jul 8;23(1):562. doi: 10.1186/s13063-022-06480-w.
PMID: 35804417DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elodie Guillaume, PhD
Université de Caen Normandie
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD in Epidemiology and Public Health
Study Record Dates
First Submitted
December 3, 2021
First Posted
December 21, 2021
Study Start
February 14, 2022
Primary Completion
February 1, 2024
Study Completion
September 1, 2024
Last Updated
December 21, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data concerning participation, place of participation, date, distance and socioeconomic status will be anonimously analysed after the two years.
Individual data is collected as part of the usual organization of organized breast cancer screening. It is the authorized structure that manages these data.